Chou Laboratory Team

Dr. Chou's research laboratory focuses on regenerative blood cellular therapy, the mechanisms of normal human hematopoietic development, and how these become disrupted in hematologic diseases. Her NIH-funded laboratory uses induced pluripotent stem cells (iPSCs) and primary human cells to both model blood diseases and create customized iPSCs with rare blood group antigen combinations as renewable sources of red cells. Translational work from her lab has been at the forefront of integrating molecular technologies into clinical transfusion medicine practice and developing novel tools to improve red cell therapy, particularly for individuals with sickle cell disease.